About Aerie Pharma
Aerie Pharma is a company based in Bedminster (United States) founded in 2005 was acquired by Alcon in August 2022.. Aerie Pharma has raised $82.61 million across 7 funding rounds from investors including Alcon, Blackstone and TPG. Aerie Pharma has completed 1 acquisition, including Avizorex Pharma. Aerie Pharma operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
- Headquarter Bedminster, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aerie Pharmaceuticals,Inc.,
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
204 people
Leadership Team
148 people
Sales and Marketing
74 people
Senior Team
64 people
Product Management Team
47 people
Human Resources and Administration
41 people
Finance and Accounting
36 people
Legal and Compliance
30 people
Unlock access to complete
Funding Insights of Aerie Pharma
Aerie Pharma has successfully raised a total of $82.61M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $41.25 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $41.2M
-
First Round
First Round
(12 Oct 2005)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Post-IPO - Aerie Pharma | Valuation |
investors |
|
| Feb, 2018 | Amount | Post-IPO - Aerie Pharma | Valuation |
investors |
|
| Sep, 2014 | Amount | Post-IPO - Aerie Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aerie Pharma
Aerie Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Blackstone and TPG. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Early- to growth-stage startups are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aerie Pharma
Aerie Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Avizorex Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of drugs for the treatment of dry eye disease
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aerie Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aerie Pharma Comparisons
Competitors of Aerie Pharma
Aerie Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aerie Pharma
Frequently Asked Questions about Aerie Pharma
When was Aerie Pharma founded?
Aerie Pharma was founded in 2005.
Where is Aerie Pharma located?
Aerie Pharma is headquartered in Bedminster, United States. It is registered at Bedminster, New Jersey, United States.
Is Aerie Pharma a funded company?
Aerie Pharma is a funded company, having raised a total of $82.61M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $125M, raised on Oct 12, 2005.
What does Aerie Pharma do?
Aerie Pharma was founded in 2005 in Bedminster, United States, within the pharmaceutical sector focused on ophthalmology. Therapies for ophthalmological conditions, including glaucoma and dry eye, are developed through a pipeline featuring drugs such as Rocklatan and Rhopressa. Drug delivery systems are also provided to address retinal diseases and related needs. Operations center on research and product innovation for eye health treatments.
Who are the top competitors of Aerie Pharma?
Aerie Pharma's top competitors include Annexon, Alimera Sciences and MeiraGTx.
How many acquisitions has Aerie Pharma made?
Aerie Pharma has made 1 acquisition, including Avizorex Pharma.
Who are Aerie Pharma's investors?
Aerie Pharma has 6 investors. Key investors include Alcon, Blackstone, TPG, Sofinnova, and Osage University Partners.